netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
 
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Notes:

Chapter review date:

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,0)
04.01.01 Hypnotics (1,1)
Benzodiazepines (1,3)
Zaleplon, Zolpidem and Zopiclone (2,1)
Clomethiazole (Chlormethiazole) (1,0)
Antihistamines (1,0)
Alcohol (0,0)
Sodium oxybate (1,0)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (4,2)
Buspirone (0,1)
Beta blockers (0,0)
Meprobamate (0,1)
04.01.03 Barbiturates (0,4)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (0,7)
First-Generation Antipsychotic Drugs (8,0)
Second-Generation Antipsychotic Drugs (10,6)
04.02.02 Antipsychotic depot injections (8,6)
04.02.03 Drugs used for mania and hypomania (1,2)
Benzodiazepines (0,1)
Antipsychotic drugs (0,0)
Carbamazepine (1,0)
Valproic acid (1,0)
Lithium (2,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (4,7)
Related antidepressants (1,1)
04.03.02 Monoamine-oxidase inhibitors (2,1)
Reverible MAOIs (1,0)
04.03.03 Selective serotonin re-uptake inhibitors (5,2)
04.03.04 Other antidepressant drugs (6,3)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (5,0)
Cocaine (0,0)
04.05 Drugs used in the treatment of obesity (0,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestingal tract (1,0)
04.05.02 Centrally acting appetite suppressants (0,3)
04.06 Drugs used in nausea and vertigo (0,0)
Antihistamines (4,1)
Phenothiazines and related drugs (8,2)
Domperidone and metoclopramide (3,0)
5HT3 antagonists (2,4)
Neurokinin receptor antagonist (2,1)
Cannabinoid (0,1)
Hyoscine (2,0)
Other drugs for Ménière's disease (1,0)
04.07 Analgesics (0,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
Compound analgesic preparations (6,5)
04.07.02 Opioid analgesics (17,22)
Weak opioids (0,0)
Strong opioids (0,0)
Breakthrough pain (0,0)
Injectable (0,0)
Other (0,0)
04.07.03 Neuropathic pain (4,1)
Trigeminal neuralgia (1,2)
Postherpetic neuralgia (0,0)
Chronic facial pain (0,0)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
Analgesics (0,4)
5HT1 agonists (3,4)
Ergot alkaloids (0,2)
Anti-emetics (0,0)
Other drugs for migrane (0,1)
04.07.04.02 Prophylaxis of migraine (3,4)
04.07.04.03 Cluster headache (0,0)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (0,1)
Partial seizures with or without secondary generalisation (0,0)
Generalised seizures (0,0)
Carbamazepine and Oxcarbazepine (2,1)
Ethosuximide (1,0)
Gabapentin and pregabalin (2,0)
Lacosamide (1,0)
Lamotrigine (1,0)
Levetiracetam (2,0)
Perampanel (0,0)
Phenobarbital and primidone (2,0)
Phenytoin (1,0)
Retigabine (1,0)
Rufinamide (0,0)
Rufinamide (0,0)
Tiagabine (0,1)
Topiramate (1,0)
Valproate (2,0)
Vigabatrin (1,0)
Zonisamide (1,0)
Benzodiazepines (2,0)
Other Drugs (1,1)
04.08.02 Drugs used in status epilepticus (9,1)
04.08.03 Febrile convulsions (0,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (0,1)
Dopamine receptor agonists (4,4)
Levodopa (3,0)
Monoamine-oxidase-B inhibitors (2,0)
Catachol-O-methyltransferase inhibitors (3,1)
Amantadine (1,0)
Mild to moderate dementia in Parkinsons disease (0,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (3,1)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (2,7)
Torsion dystonias and other involuntary movements (1,0)
04.09.04 Restless leg syndrome (2,0)
04.10 Drugs used in substance dependence (0,0)
Alcohol dependence (0,0)
Cigarette smoking (0,0)
Opioid dependence (0,0)
04.10.01 Alcohol dependence (4,0)
04.10.02 Nicotine dependence (3,0)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (3,0)
Adjunctive therapy and symptomatic treatment (1,0)
Opioid-receptor antagonists (2,0)
04.11 Drugs for dementia (5,0)
netFormulary